Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Forero

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|May 1, 2019
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 BlockadeAleix Prat, Tomás Pascual, Carmine De Angelis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelinesRobert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 15, 2015
Breast Cancer Version 2.2015William J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
NCCN Guidelines Insights Breast Cancer, Version 1.2016William J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
Breast Cancer Research and Treatment|May 8, 2020
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
NPJ Breast Cancer|May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2015
Hodgkin lymphoma, version 2.2015Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Breast cancer, version 3.2013: featured updates to the NCCN guidelinesRichard L Theriault, Robert W Carlson, Craig Allred, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Breast cancer version 3.2014William J Gradishar, Benjamin O Anderson, Sarah L Blair, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|May 1, 2019
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 BlockadeAleix Prat, Tomás Pascual, Carmine De Angelis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelinesRobert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 15, 2015
Breast Cancer Version 2.2015William J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
NCCN Guidelines Insights Breast Cancer, Version 1.2016William J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
Breast Cancer Research and Treatment|May 8, 2020
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
NPJ Breast Cancer|May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2015
Hodgkin lymphoma, version 2.2015Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Breast cancer, version 3.2013: featured updates to the NCCN guidelinesRichard L Theriault, Robert W Carlson, Craig Allred, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Breast cancer version 3.2014William J Gradishar, Benjamin O Anderson, Sarah L Blair, et al.
Pageof 18